Lurie Cancer Center Announces 2022 Translational Bridge Award Recipients

Lurie Cancer Center is pleased to announce the recipients of its 2022 Translational Bridge Program awards, selected to foster collaboration and mentorship with the goal of translating basic science research into novel clinical approaches.

The following awardees and the focal point of their research project are:

PANCREATIC CANCER

Overcoming Resistance to Oncolytic Virotherapy and PD-1 Blockade in Advanced Pancreatic Cancer

Bin Zhang, PhD
Hematology and Oncology, Microbiology-Immunology

Devalingam Mahalingham, MBBChBAO
Hematology and Oncology

Masato Ikeda, PhD
Trainee

BREAST CANCER

Establishing preclinical efficacy of licochalcone A for primary prevention of invasive breast cancer

Seema Khan, MD
Breast Surgery, Cancer Prevention

Marcelo Bonini, PhD
Hematology and Oncology

Atieh Hajirahimkhan, PhD
Postdoctoral Fellow

BRAIN CANCER

Production of B-cell vaccination for a first-in human clinical trial for newly diagnosed glioblastoma

Catalina Lee-Chang, PhD
Neurological Surgery

Maciej Lesniak, MD
Neurological Surgery

Roger Stupp, MD
Neurological Surgery, Neuro-Oncology, Hematology and Oncology

Gustavo Ignacio Vasquez-Cervantes, PhD
Trainee

Read more about the Translational Bridge Program